WORCESTER, Mass., March 20, 2008 (PRIME NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today clarified the stance of Dr. Gerald Bernstein, the Company's Vice-President for Medical Affairs.
